U.S. jury finds AbbVie liable for misrepresentation in first AndroGel verdict

NEW YORK (Reuters) - A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages.

Source: Reuters: Health - July 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news